EU Warns Of Anaphylaxis With MS Drug ‘Months Or Years’ After Start Of Treatment

 
• By Ian Schofield
Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science to detection, monitoring, and prevention of adverse effects with pharmaceutical product
The EU has flagged up a new safety concern over glatiramer acetate • Source: Shutterstock

More from Europe

More from Geography